Good & Not So Good News From the UK
A well-timed announcement improving public funded access for the Freestyle Libre sensor monitoring system was made by the UK Government on World Diabetes Day.
Local health care bodies will decide who can be prescribed the device used by Prime Minister Theresa May and it is expected around 45,000 people with Type One diabetes could qualify.
Meanwhile around 1.5 million people with diabetes in the UK are not getting the care they need, in what health campaigners describe as a “bleak picture” of treatment.
Although a growing number of people with diabetes in England and Wales are being properly cared for, four in 10 are still not getting the care recommended by the UK National Institute for Health and Care Excellence, the latest national diabetes audit has found. Patients are supposed to receive at least eight forms of care, including blood tests to measure cardiovascular risk, kidney function, and glucose control and urine tests for kidney disease.
More here: https://www.theguardian.com/society/2018/oct/24/diabetes-ticking-time-bomb-nhs
and
Artificial Pancreas
Dexcom, Inc. is a company that develops, manufactures and distributes continuous glucose monitoring systems for diabetes management.
The US based company has set its sights on an artificial pancreas with the acquisition of the TypeZero Technologies company.
More here: https://www.diabetes.co.uk/ [original link incomplete]
Pump Audit
The UK’s National Health Service has published results of a national insulin pump audit –